Sponsor

Praxis Precision Medicines Inc.

United States 99 High Street Floor 30th, 02110-2345, United States

About the sponsor

Clinical research focuses on adult epilepsy, including focal epilepsy and primary generalized tonic-clonic seizures, with attention to seizure control and treatment response in people using background anti-seizure medications.

Focal onset seizures
Primary generalized tonic-clonic seizures
Seizure frequency

The sponsor also studies photoparoxysmal electroencephalogram response in epilepsy, reflecting interest in seizure-related neurophysiological markers.

About Specializations

Praxis Precision Medicines Inc. runs clinical trials in conditions such as Partial seizures, Generalised tonic-clonic seizure, Epileptic encephalopathy, Epilepsy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

7 clinical trials

Generalised tonic-clonic seizure+1

Recruiting

Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

InvestigationalNo placebo

Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:PRAX-628
Sponsor:Praxis Precision Medicines Inc.

Contact Research Centre

Epileptic encephalopathy

Recruiting

Study of Elsunersen in Children with SCN2A Developmental and Epileptic Encephalopathy to Reduce Seizures

InvestigationalNo placebo

Study of Elsunersen in Children with SCN2A Developmental and Epileptic Encephalopathy to Reduce Seizures

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:5'-MOEMC-(SP)-MOEMC-(P)-MOEA-(P)-MOEMC-(P)-MOEG-(P)-MOEA-(P)-DMC-(SP)-DA-(SP)-DT-(SP)-DA-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DMC-(SP)-MOET-(P)-MOEA-(SP)-MOEMC-(SP)-MOEA 3'
Sponsor:Praxis Precision Medicines Inc.